Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types

• Main Authors: Martin Ryser (Author), Valérie Berlaimont (Author), Naveen Karkada (Author), Attila Mihalyi (Author), Rino Rappuoli (Author), Robbert van der Most (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Substantial heterogeneity has been reported in efficacy against high-grade cervical intraepithelial neoplasia (CIN) irrespective of HPV type in phase III results for bivalent and quadrivalent human papillomavirus virus (HPV) vaccines (AS04-HPV and qHPV). Real-world data recently confirme...